To Explore the Effect of GH on Outcomes of IVF and Telomerase Activity of Granulosa Cells in Women With POR

GH Clinical Trial

Official title: To Explore the Effect of Growth Hormone on Outcomes of in Vitro Fertilisation and Telomerase Activity of Granulosa Cells in Women With Poor Ovarian Response

Status Not yet recruiting

Clinical Trial Summary

It is still a big difficult clinical problem for patients with poor ovarian reserve undergoing in vitro fertilization. The decrease in both quality and quantity of egg are the main cause for poor clinical prognosis. Growth hormone (GH) is currently one of the main adjuvant for improving pregnancy outcomes in patients with POR, and the investigators' previous retrospective study suggested GH was effective in live birth rate in subgroup of patients with POR older than 35 years old. To further figure out the mechanism of GH effectiveness in POR patients and the effect on clinical outcomes in POR patients, the investigators designed this prospective observational cohort study.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• GH
• Poor Ovarian Reserve Based on POSEIDON

• NCT number: NCT04384744
• Study type: Observational
• Source: Guangzhou First People's Hospital
• Contact: meihong Cai, master
• Phone: 15889936054
• Email: caimhong@mail2.sysu.edu.cn
• Status: Not yet recruiting
• Start date: May 26, 2020
• Completion date: November 30, 2021